FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014908478> ?p ?o ?g. }

• W2014908478 endingPage "A158" @default.
• W2014908478 startingPage "A158" @default.
• W2014908478 abstract "<h3>Background</h3> Lung cancer is the commonest form of malignant disease in the Western World, and 95% of patients die within 5 years of presentation. Palliation of symptoms is therefore an important aspect of the treatment: up to 30% will develop large airway obstruction due to tumour with ensuing distressing breathlessness and this may be life threatening. Protection of the airway by stenting may be difficult and is traditionally carried out under general anaesthesia and fluoroscopy. In our regional unit we have developed a service for the insertion of self-expanding Gianturco stents under local anaesthesia using the fibreoptic bronchoscope (FOB) and direct vision for the treatment of malignant airway tumours, and we now report our 20-year experience. <h3>Methods</h3> A review of all stenting procedures carried out in our unit between 1990 and 2009, looking for tumour type, number and site of stents, procedure complications, and survival. <h3>Results</h3> 236 patients (mean age 64 years (range 21–89)) had 414 stents inserted during 242 procedures (mean 1.7 stents/procedure (1–4)); 184 patients for primary lung tumours (49% squamous cell, 25% small cell, 15% adenocarcinoma, 11% unknown), 33 for secondary malignancy, and four for benign conditions (following fully informed consent). There were no operative deaths, but four patients developed a pneumothorax, three haemoptysis, and two procedure-related chest infections. Mean survival of patients with primary lung cancer improved from 103 days (range 1–488) between 1990 and 1999 to 150 days (5–910) between 2000 and 2009. <h3>Conclusion</h3> We conclude that Gianturco stents are safe in relieving malignant airway obstruction, with a low complication rate: higher complication rates reported in others studies may be due to poor patient selection or stent placement. Survival improved in our patients over time, suggesting better patient selection or improvement in coexisting treatment modalities (eg, oral chemotherapy and palliative care). Our technique of endobronchial stent insertion using FOB is simple and effective without the need for thoracic surgical facilities, and we therefore recommend its use to other clinicians who are charged with treating patients with this common and distressing disease." @default.
• W2014908478 created "2016-06-24" @default.
• W2014908478 creator A5009570369 @default.
• W2014908478 creator A5047146407 @default.
• W2014908478 creator A5084831875 @default.
• W2014908478 creator A5088249472 @default.
• W2014908478 date "2010-11-16" @default.
• W2014908478 modified "2023-09-26" @default.
• W2014908478 title "P192 Fibreoptic bronchoscopic insertion of the Gianturco stent for tracheobronchial obstruction in patients with cancer at a lung cancer tertiary referral centre: 20 year experience" @default.
• W2014908478 doi "https://doi.org/10.1136/thx.2010.151043.43" @default.
• W2014908478 hasPublicationYear "2010" @default.
• W2014908478 type Work @default.
• W2014908478 sameAs 2014908478 @default.
• W2014908478 citedByCount "0" @default.
• W2014908478 crossrefType "journal-article" @default.
• W2014908478 hasAuthorship W2014908478A5009570369 @default.
• W2014908478 hasAuthorship W2014908478A5047146407 @default.
• W2014908478 hasAuthorship W2014908478A5084831875 @default.
• W2014908478 hasAuthorship W2014908478A5088249472 @default.
• W2014908478 hasBestOaLocation W20149084781 @default.
• W2014908478 hasConcept C105922876 @default.
• W2014908478 hasConcept C121608353 @default.
• W2014908478 hasConcept C126322002 @default.
• W2014908478 hasConcept C126838900 @default.
• W2014908478 hasConcept C141071460 @default.
• W2014908478 hasConcept C2776256026 @default.
• W2014908478 hasConcept C2778329176 @default.
• W2014908478 hasConcept C2778333281 @default.
• W2014908478 hasConcept C2778583881 @default.
• W2014908478 hasConcept C2779399171 @default.
• W2014908478 hasConcept C2781182431 @default.
• W2014908478 hasConcept C71924100 @default.
• W2014908478 hasConceptScore W2014908478C105922876 @default.
• W2014908478 hasConceptScore W2014908478C121608353 @default.
• W2014908478 hasConceptScore W2014908478C126322002 @default.
• W2014908478 hasConceptScore W2014908478C126838900 @default.
• W2014908478 hasConceptScore W2014908478C141071460 @default.
• W2014908478 hasConceptScore W2014908478C2776256026 @default.
• W2014908478 hasConceptScore W2014908478C2778329176 @default.
• W2014908478 hasConceptScore W2014908478C2778333281 @default.
• W2014908478 hasConceptScore W2014908478C2778583881 @default.
• W2014908478 hasConceptScore W2014908478C2779399171 @default.
• W2014908478 hasConceptScore W2014908478C2781182431 @default.
• W2014908478 hasConceptScore W2014908478C71924100 @default.
• W2014908478 hasIssue "Suppl 4" @default.
• W2014908478 hasLocation W20149084781 @default.
• W2014908478 hasLocation W20149084782 @default.
• W2014908478 hasOpenAccess W2014908478 @default.
• W2014908478 hasPrimaryLocation W20149084781 @default.
• W2014908478 hasRelatedWork W2011177479 @default.
• W2014908478 hasRelatedWork W2058465633 @default.
• W2014908478 hasRelatedWork W206366597 @default.
• W2014908478 hasRelatedWork W2461472718 @default.
• W2014908478 hasRelatedWork W2471039675 @default.
• W2014908478 hasRelatedWork W2902148150 @default.
• W2014908478 hasRelatedWork W2912715060 @default.
• W2014908478 hasRelatedWork W2978457763 @default.
• W2014908478 hasRelatedWork W4245540480 @default.
• W2014908478 hasRelatedWork W4310267044 @default.
• W2014908478 hasVolume "65" @default.
• W2014908478 isParatext "false" @default.
• W2014908478 isRetracted "false" @default.
• W2014908478 magId "2014908478" @default.
• W2014908478 workType "article" @default.